Back to Search
Start Over
Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations
- Authors :
- Tausch, E. Ljungström, V. Agathangelidis, A. Zapatka, M. Scarfò, L. Jebaraj, B.M.C. Yosifov, D.Y. Müller, A. Munugalavadla, V. Degenhardt, J.D. Ghia, P. Rosenquist, R. Stilgenbauer, S.
- Publication Year :
- 2022
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......2127..8d7b92c5d6a65a954189c49e9b199209